Cancer Treatment Market Research Reports & Industry Analysis
Cancer is a disease characterized by uncontrolled cell proliferation. Of the more than 100 types of cancer, lung, breast, and colorectal cancer account for nearly half of new cases per year in the United States. Lung cancer, which is highly correlated with cigarette smoking, is responsible for more deaths than any other form of cancer. Cigarette smoking and other environmental factors are associated with the majority of cancers.
With the growing incidence of cancer, a growing and aging world population and significant medical advances, there will continue to be phenomenal growth in the market for cancer diagnosis and treatment products.
Cancer Treatment Industry Research & Market Reports
-
Uterine Serous Carcinoma - Epidemiology Forecast - 2032
... Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Uterine Serous Carcinoma Understanding The ... Read More
-
Larynx Cancer - Epidemiology Forecast to 2032
... France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Larynx Cancer Understanding The DelveInsight Larynx Cancer ... Read More
-
B-Cell Chronic Lymphocytic Leukemia - Epidemiology Forecast to 2032
... EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 B-Cell Chronic Lymphocytic ... Read More
-
Non-Hodgkin's Lymphoma - Market Insight, Epidemiology and Market Forecast -2032
... States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Non-Hodgkin's Lymphoma market report provides current treatment practices, emerging drugs, Non-Hodgkin's Lymphoma market share of the individual therapies, current and forecasted Non-Hodgkin's Lymphoma ... Read More
-
Metastatic Castration-Resistant Prostate Cancer (mCRPC) - Epidemiology Forecast to 2032
... United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Metastatic ... Read More
-
Castrate-Resistant Prostate Cancer (CRPC)- Epidemiology Forecast to 2032
... EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Castrate-Resistant Prostate Cancer ... Read More
-
Relapsed B-Cell Small Lymphocytic Lymphoma - Epidemiology Forecast - 2032
... United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Relapsed ... Read More
-
Radiation induced-Oral Mucositis (RIOM) in Head and neck Cancer (HNC)- Epidemiology Forecast to 2032
... and neck Cancer (HNC) epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, ... Read More
-
Synovial sarcoma (SS) - Epidemiology Forecast to 2032
... Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Synovial sarcoma (SS) Understanding The ... Read More
-
Hepatocellular Carcinoma - Epidemiology Forecast to 2032
... France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Hepatocellular Carcinoma Understanding The DelveInsight Hepatocellular Carcinoma ... Read More
-
Malignant Melanoma - Epidemiology Forecast to 2032
... France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Malignant Melanoma Understanding The DelveInsight Malignant Melanoma ... Read More
-
Pancreatic Cancer - Epidemiology Forecast to 2032
... France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Pancreatic Cancer Understanding The DelveInsight Pancreatic Cancer ... Read More
-
Advanced Pancreatic Cancer - Epidemiology Forecast to 2032
... Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Advanced Pancreatic Cancer Understanding The ... Read More
-
Refractory Metastatic Melanoma - Epidemiology Forecast to 2032
... Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Refractory Metastatic Melanoma Understanding The ... Read More
-
Large Granular Lymphocyte Leukemia/ Aggressive NK-cell leukemia - Market Insight, Epidemiology and Market Forecast -2032
... well as the Large Granular Lymphocyte Leukemia/ Aggressive NK-cell leukemia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Large Granular Lymphocyte Leukemia/ Aggressive NK-cell leukemia market ... Read More
-
Chronic Phase Chronic Myeloid Leukemia - Epidemiology Forecast - 2032
... United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Chronic ... Read More
-
Colorectal Cancer (CRC) - Epidemiology Forecast to 2032
... Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Colorectal Cancer (CRC) Understanding The ... Read More
-
Global Nanoparticle Drug Delivery Systems Market Size, Status and Forecast 2021-2027
... 8103 million by 2027, from US$ 4089 million in 2020, at a CAGR of 10% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key ... Read More
-
Acute Lymphocytic Leukemia (ALL) - Epidemiology Forecast - 2032
... EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Acute Lymphocytic Leukemia ... Read More
-
Severe Toxicities in Lymphoma - Epidemiology Forecast to 2032
... EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Severe Toxicities in ... Read More
-
Endometrial Cancer - Epidemiology Forecast to 2032
... France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Endometrial Cancer Understanding The DelveInsight Endometrial Cancer ... Read More
-
Adenoid Cystic Carcinoma (ACC) - Epidemiology Forecast to 2032
... EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Adenoid Cystic Carcinoma ... Read More
-
Hormone Receptor (HR) positive/ Human Epidermal Receptor 2 (HER2) negative Breast Cancer - Market Insight, Epidemiology and Market Forecast -2032
... 2 (HER2) negative Breast Cancer, historical and forecasted epidemiology as well as the Hormone Receptor (HR) positive/ Human Epidermal Receptor 2 (HER2) negative Breast Cancer market trends in the United States, EU5 (Germany, Spain, Italy, ... Read More
-
Relapsed/Refractory Multiple Myeloma (RRMM) - Market Insight, Epidemiology and Market Forecast -2032
... (RRMM) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Relapsed/Refractory Multiple Myeloma (RRMM) market report provides current treatment practices, emerging drugs, Relapsed/Refractory Multiple Myeloma (RRMM) market ... Read More
-
Castrate-Sensitive Prostate Cancer (CSPC)- Epidemiology Forecast to 2032
... EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Castrate-Sensitive Prostate Cancer ... Read More
Research Assistance
